Pfizer Inc said on Tuesday it is seeking US authorisation of its experimental antiviral Covid-19 pill that cut the chance of hospitalisation or death for adults at risk of severe disease by 89 per cent in a clinical trial. Pfizer said it completed submission of its application for emergency use authorisation (EUA) of the drug, Paxlovid, with the US Food …
Read More »Pfizer files for US authorisation of promising Covid-19 antiviral pill
November 17, 2021